The action of D-dopachrome tautomerase as an adipokine in adipocyte lipid metabolism

PLoS ONE

Volumn 7, Issue 3, 2012, Pages

  Iwata, Takeo ^a   Taniguchi, Hisaaki ^a   Kuwajima, Masamichi ^a,b   Taniguchi, Takako ^a   Okuda, Yuko ^a   Sukeno, Akiko ^a   Ishimoto, Kyoko ^a   Mizusawa, Noriko ^a   Yoshimoto, Katsuhiko ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

^b Taijukai Kaisei General Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYL COENZYME A CARBOXYLASE; ADENOVIRUS VECTOR; ADIPOCYTOKINE; CYCLIC AMP DEPENDENT PROTEIN KINASE; DOPACHROME TAUTOMERASE; FATTY ACID; HORMONE SENSITIVE LIPASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; MESSENGER RNA; RECOMBINANT DOPACHROME TAUTOMERASE; RECOMBINANT ENZYME; SERINE; SHORT HAIRPIN RNA; UNCLASSIFIED DRUG; DOPACHROME ISOMERASE; ISOMERASE; PRIMER DNA;

ADENOVIRUS; ADIPOCYTE; ADIPOGENESIS; ADIPOSE TISSUE; ANIMAL TISSUE; ARTICLE; BODY MASS; CANCER CELL CULTURE; CELL DIFFERENTIATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; DDT GENE; DOWN REGULATION; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; FATTY ACID BLOOD LEVEL; GENE; GENE EXPRESSION; GLUCOSE INTOLERANCE; HUMAN; HUMAN CELL; HUMAN TISSUE; INSULIN RESISTANCE; INTRAABDOMINAL FAT; LIPID METABOLISM; LIPOGENESIS; LIPOLYSIS; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OBESITY; PROADIPOCYTE; PROTEOMICS; SIGNAL TRANSDUCTION; SUBCUTANEOUS FAT; VIRAL GENE DELIVERY SYSTEM; ANIMAL; FLUORESCENCE MICROSCOPY; GENE SILENCING; GENETICS; METABOLISM; METHODOLOGY; PHOSPHORYLATION; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ADENOVIRIDAE; MUS;

ADIPOCYTES; ADIPOKINES; AMP-ACTIVATED PROTEIN KINASES; ANIMALS; BLOTTING, WESTERN; BODY MASS INDEX; CELL DIFFERENTIATION; DNA PRIMERS; GENE KNOCKDOWN TECHNIQUES; HUMANS; INTRAMOLECULAR OXIDOREDUCTASES; LIPID METABOLISM; MICE; MICROSCOPY, FLUORESCENCE; PHOSPHORYLATION; PROTEOMICS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

EID: 84858028318     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0033402     Document Type: Article

References (44)

1. Rosen ED, Spiegelman BM, (2006) Adipocytes as regulators of energy balance and glucose homeostasis. Nature 444: 847-853.
2. Ronti T, Lupattelli G, Mannarino E, (2006) The endocrine function of adipose tissue: an update. Clin Endocrinol (Oxf) 64: 355-365.
3. Odh G, Hindemith A, Rosengren AM, Rosengren E, Rorsman H, (1993) Isolation of a new tautomerase monitored by the conversion of D-dopachrome to 5,6-dihydroxyindole. Biochem Biophys Res Commun 197: 619-624.
4. Nishihira J, Fujinaga M, Kuriyama T, Suzuki M, Sugimoto H, et al. (1998) Molecular cloning of human D-dopachrome tautomerase cDNA: N-terminal proline is essential for enzyme activation. Biochem Biophys Res Commun 243: 538-544.
5. Sugimoto H, Taniguchi M, Nakagawa A, Tanaka I, Suzuki M, et al. (1999) Crystal structure of human D-dopachrome tautomerase, a homologue of macrophage migration inhibitory factor, at 1.54 Å resolution. Biochemistry 38: 3268-3279.
6. Bloom BR, Bennett B, (1966) Mechanism of a reaction in vitro associated with delayed-type hypersensitivity. Science 153: 80-82.
7. Calandra T, Bernhagen J, Mitchell RA, Bucala R, (1994) The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor. J Exp Med 179: 1895-1902.
8. Rosengren E, Bucala R, Åman P, Jacobsson L, Odh G, et al. (1996) The immunoregulatory mediator macrophage migration inhibitory factor (MIF) catalyzes a tautomerization reaction. Mol Med 2: 143-149.
9. Coleman AM, Rendon BE, Zhao M, Qian MW, Bucala R, et al. (2008) Cooperative regulation of non-small cell lung carcinoma angiogenic potential by macrophage migration inhibitory factor and its homolog, D-dopachrome tautomerase. J Immunol 181: 2330-2337.
10. Merk M, Zierow S, Leng L, Das R, Du X, et al. (2011) The D-dopachrome tautomerase (DDT) gene products a cytokine and functional homolog of macrophage migration inhibitory factor (MIF). Proc Natl Acad Sci U S A 108: E577-E585.
11. Guiherme A, Virbasius JV, Puri V, Czech MP, (2008) Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes. Nat Rev Mol Cell Biol 9: 367-377.
12. Hardie DG, Hawley SA, Scott JW, (2006) AMP-activated protein kinase- development of the energy sensor concept. J Physiol 574 (Pt1): 7-15.
13. Carling D, Sanders MJ, Woods A, (2008) The regulation of AMP-activated protein kinase by upstream kinases. Int J Obes (Lond) 32 (Suppl 4): S55-59.
14. Hurley RL, Barré LK, Wood SD, Anderson KA, Kemp BE, et al. (2006) Regulation of AMP-activated protein kinase by multisite phosphorylation in response to agents that elevate cellular cAMP. J Biol Chem 281: 36662-36672.
15. Djouder N, Tuerk RD, Suter M, Salvioni P, Thali RF, et al. (2010) PKA phosphorylates and inactivates AMPKα to promote efficient lipolysis. EMBO J 29: 469-481.
16. Steinberg GR, Kemp BE, (2009) AMPK in health and disease. Physiol Rev 89: 1025-1078.
17. Assifi MM, Suchankova G, Constant S, Prentki M, Saha AK, et al. (2005) AMP-activated protein kinase and coordination of hepatic fatty acid metabolism of starved/carbohydrate-refed rats. Am J Physiol Endocrinol Metab 289: E794-800.
18. Garton AJ, Yeaman SJ, (1990) Identification and role of the basal phosphorylation site on hormone-sensitive lipase. Eur J Biochem 191: 245-250.
19. Iwata T, Kuwajima M, Sukeno A, Ishimaru N, Hayashi Y, et al. (2009) YKL-40 secreted from adipose tissue inhibits degradation of type I collagen. Biochem Biophys Res Commun 388: 511-516.
20. Wabitsch M, Brenner RE, Melzner I, Braun M, Möller P, et al. (2001) Characterization of a human preadipocyte cell strain with high capacity for adipose differentiation. Int J Obes Relat Metab Disord 25: 8-15.
21. Sonesson B, Rosengren E, Hansson AS, Hansson C, (2003) UVB-induced inflammation gives increased D-dopachrome tautomerase activity in blister fluid which correlates with macrophage migration inhibitory factor. Exp Dermatol 12: 278-282.
22. Hiyoshi M, Konishi H, Uemura H, Matsuzaki H, Tsukamoto H, et al. (2009) D-Dopachrome tautomerase is a candidate for key proteins to protect the rat liver damaged by carbon tetrachloride. Toxicology 255: 6-14.
23. Yang F, Yan S, He Y, Wang F, Song S, et al. (2008) Expression of hepatitis B virus proteins in transgenic mice alters lipid metabolism and induces oxidative stress in the liver. J Hepatol 48: 12-19.
24. Strey CW, Winters MS, Markiewski MM, Lambris JD, (2005) Partial hepatectomy induced liver proteome changes in mice. Proteomics 5: 318-325.
25. Woods A, Azzout-Marniche D, Foretz M, Stein SC, Lemarchand P, et al. (2000) Characterization of the role of AMP-activated protein kinase in the regulation of glucose-activated gene expression using constitutively active and dominant negative forms of the kinase. Mol Cell Biol 20: 704-6711.
26. Zhou G, Myers R, Li Y, Chen Y, Shen X, et al. (2001) Role of AMP-activated protein kinase in mechanism of metformin action. J Clin Invest 108: 1167-1174.
27. Minokoshi Y, Kim YB, Peroni OD, Fryer LG, Müller C, et al. (2002) Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase. Nature 415: 339-343.
28. Yamauchi T, Kamon J, Minokoshi Y, Ito Y, Waki H, et al. (2002) Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med 8: 1288-1295.
29. Hertzel AV, Bernlohr DA, (2000) The mammalian fatty acid-binding protein multigene family: molecular and genetic insights into function. Trends Endocrinol Metab 11: 175-180.
30. Hotamisligil GS, Johnson RS, Distel RJ, Ellis R, Papaioannou VE, et al. (1996) Uncoupling of obesity from insulin resistance through a targeted mutation in aP2, the adipocyte fatty acid binding protein. Science 274: 1377-1379.
31. Uysal KT, Scheja L, Wiesbrock SM, Bonner-Weir S, Hotamisligil GS, (2000) Improved glucose and lipid metabolism in genetically obese mice lacking aP2. Endocrinology 141: 3388-3396.
32. Makowski L, Boord JB, Maeda K, Babaev VR, Uysal KT, et al. (2001) Lack of macrophage fatty-acid-binding protein aP2 protects mice deficient in apolipoprotein E against atherosclerosis. Nat Med 7: 699-705.
33. Tontonoz P, Nagy L, Alvarez JG, Thomazy VA, Evans RM, (1998) PPARγ promotes monocyte/macrophage differentiation and uptake of oxidized LDL. Cell 93: 241-252.
34. He GP, Muise A, Li AW, Ro HS, (1995) A eukaryotic transcriptional repressor with carboxypeptidase activity. Nature 378: 92-96.
35. Krempler F, Breban D, Oberkofler H, Esterbauer H, Hell E, et al. (2000) Leptin, peroxisome proliferator-activated receptor-γ, and CCAAT/enhancer binding protein-α mRNA expression in adipose tissue of humans and their relation to cardiovascular risk factors. Arterioscler Thromb Vasc Biol 20: 443-449.
36. Unger RH, (1995) Lipotoxicity in the pathogenesis of obesity-dependent NIDDM genetic and clinical implications. Diabetes 44: 863-870.
37. Guilherme A, Virbasius JV, Czech MP, (2008) Adipocyte dysfunction linking obesity to insulin resistance and type 2 diabetes. Nat Rev Mol Cell Biol 9: 367-377.
38. Londos C, Brasaemle DL, Schultz CJ, Adler-Wailes DC, Levin DM, et al. (1999) On control of lipolysis in adipocytes. Ann NY Acad Sci 18: 155-168.
39. Skurk T, Herder C, Kräft I, Müller-Scholze S, Hauner H, et al. (2005) Production and release of macrophage migration inhibitory factor from human adipocytes. Endocrinology 146: 1006-1011.
40. Kleemann R, Bucala R, (2010) Macrophage migration inhibitory factor: critical role in obesity, insulin resistance, and associated comorbidities. Mediators Inflamm 2010: 610479.
41. Koska J, Stefan N, Dubois S, Trinidad C, Considine RV, et al. (2009) mRNA concentrations of MIF in subcutaneous abdominal adipose cells are associated with adipocyte size and insulin action. Int J Obes (Lond) 33: 842-850.
42. Atsumi T, Cho YR, Leng L, McDonald C, Yu T, et al. (2007) The proinflammatory cytokine macrophage migration inhibitory factor regulates glucose metabolism during systemic inflammation. J Immunol 179: 5399-5406.
43. Verschuren L, Kooistra T, Bernhagen J, Voshol PJ, Ouwens DM, et al. (2009) MIF deficiency reduces chronic inflammation in white adipose tissue and impairs the development of insulin resistance, glucose intolerance, and associated atherosclerotic disease. Circ Res 105: 99-107.
44. Miller EJ, Li J, Leng L, McDonald C, Atsumi T, et al. (2008) Macrophage migration inhibitory factor stimulates AMP-activated protein kinase in the ischaemic heart. Nature 451: 578-582.